Mountain View, CA, United States of America

Xiao-Fa Lin


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2000-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Xiao-Fa Lin

Introduction

Xiao-Fa Lin is a notable inventor based in Mountain View, CA (US). She has made significant contributions to the field of pharmacology, particularly in the development of compounds for the treatment of neuropathic pain. With a total of 2 patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Xiao-Fa Lin's latest patents include innovative compounds known as phenoxymethyl piperidine derivatives. These compounds are designed for the treatment of neuropathic pain and are characterized by their ability to act as sodium channel blockers. The specific formulations include individual isomers or racemic mixtures, along with their pharmaceutically acceptable salts and N-oxides. These compounds exhibit useful pharmacological properties, making them valuable in addressing neuropathic pain conditions.

Career Highlights

Xiao-Fa Lin is currently associated with Syntex (U.S.A.) Inc., where she continues to advance her research and development efforts. Her work has been instrumental in creating effective treatments for pain management, showcasing her expertise in medicinal chemistry.

Collaborations

Throughout her career, Xiao-Fa Lin has collaborated with esteemed colleagues, including David Garrett Loughhead and Robert James Weikert. These partnerships have contributed to the success of her research and the development of her patented compounds.

Conclusion

Xiao-Fa Lin's contributions to the field of pharmacology through her innovative patents highlight her role as a leading inventor in the treatment of neuropathic pain. Her work continues to impact the medical community positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…